MET-PF — MetLife, Inc.

MetLife Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Adjusted Earnings: $1.6 billion, or $2.42 per share, up 18% and 23% year-over-year, respectively.
• Net Income: $1.1 billion, or $1.74 per share.
• Adjusted Return on Equity (ROE): 17%, at the top end of the 15%-17% target range.
• Direct Expense Ratio: 11.9%, improved from the previous year and better than the full-year target of 12.1%.
• Variable Investment Income: $518 million pretax, driven by strong private equity returns (2.9%).
• Cash at Holding Companies: $3.9 billion, within the liquidity target buffer of $3 billion to $4 billion.
• Shareholder Returns: Approximately $1.1 billion returned through share repurchases and dividends.

2. Strategic Updates and Business Highlights:

• MetLife's "New Frontier" strategy is in its second year, focusing on growth acceleration and disciplined execution across diverse business segments.
• Group Benefits: Adjusted earnings of $439 million, up 19% year-over-year, with strong sales growth (15%) and favorable life mortality trends.
• Retirement & Income Solutions (RIS): Adjusted earnings of $451 million, up 11%, supported by new product sales and variable investment income.
• Asia Region: Adjusted earnings of $487 million, up 31%, with sales growth of 22% on a constant currency basis, particularly strong in Japan and Korea.
• EMEA: Adjusted earnings of $110 million, up 33%, driven by robust volume growth.
• MetLife Investment Management (MIM): Adjusted earnings of $47 million, up 68%, with a strong pipeline for future growth.

3. Forward Guidance and Outlook:

• The company remains confident in achieving its financial commitments under the New Frontier strategy, with expectations for continued strong performance across segments.
• RIS adjusted earnings for the full year are expected to be between $1.6 billion to $1.8 billion.
• Anticipated moderation in growth rates in Asia due to strong prior year comparatives, but momentum is expected to continue.

4. Bad News, Challenges, or Points of Concern:

• Market Volatility: MIM experienced a 1.9% decrease in institutional client assets under management due to market depreciation and modest net outflows.
• Regulatory Scrutiny in Japan: Ongoing discussions with regulators regarding industry-wide issues, though no direct impact on MetLife's business has been observed.
• Disability Claims: Higher claims were noted due to new state-mandated paid family leave programs, which may require future pricing adjustments.
• Trading Losses: The company reported net investment losses primarily from trading activity, which affected net income.

5. Notable Q&A Insights:

• Sustainability of Mortality Trends: Management expressed confidence in the sustainability of favorable working-age mortality trends, though they noted the need for gradual adjustments in pricing.
• Competitive Landscape in Group Benefits: MetLife's strong sales performance is attributed to its ability to bundle products and maintain high persistency rates.
• Investment Strategy: The company is cautious about commercial mortgage loans but sees opportunities in private credit and asset-backed financing.
• PineBridge Integration: Early integration efforts post-acquisition are showing promise, with a strong pipeline and cross-selling opportunities being identified.

Overall, MetLife's Q1 2026 results reflect strong operational performance and strategic execution, despite facing some market challenges and regulatory scrutiny. The company remains optimistic about its growth trajectory and capital management strategy.